Epigenetics of uterine quiescence

子宫静止的表观遗传学

基本信息

项目摘要

The decidua, the specialized endometrial tissue positioned between the conceptus and myometrium, performs several important functions during pregnancy. While doing so, it must also remain “quiescent” or else risk compromising placental function or triggering uterine contractions and thus premature delivery. This quiescent state has been assumed to be like that of any other tissue, in that it would be abrogated by stresses that disrupt tissue homeostasis or integrity. However, our recent work in mice suggests that the decidua is unique in that it actively enforces its own quiescence, and that this occurs because decidual stromal cells (DSCs) transcriptionally silence quiescence-threatening genes via targeted promoter accrual of H3 trimethyl lysine 27 (H3K27me3), a repressive histone mark. This epigenetic program impacts a diverse set of ~800 genes, with the effects we currently understand being the suppression of type 1 immunity and wound healing responses. H3K27me3 is generated by PRC2 (Polycomb Repressive Complex 2), whose primary catalytic subunit is the histone methyltransferase EZH2 (Enhancer of Zeste Homolog 2). Here, we propose to dissect the pregnancy phenotype of mice in which Ezh2 is conditionally deleted within the uterus, with the long-term goal of gaining a greater insight into the nature of uterine quiescence and the kinds of threats to pregnancy mitigated by the decidual gene silencing program. Importantly, “Ezh2 cKO” mice form implantations sites, but they are short- lived. We hypothesize that H3K27me3-mediated gene silencing in DSCs is critical to pregnancy because it acts in umbrella fashion to enforce uterine quiescence in the face of many potential tissue stresses, including infection, allo-immune responses, tissue damage, and even placental development itself. In Aim 1, which approaches the Ezh2 cKO phenotype most generally, we will identify the kinds of pregnancy complications that result from uterine Ezh2 deficiency, as well as the kinds of tissue stresses that might trigger these complications. The Aim focuses on the stresses caused by (1) implantation and early embryonic development, (2) later placental development, (3) systemic inflammation, and (4) direct infection. Aim 2 then addresses an aspect of the Ezh2 cKO decidua that is already clear, namely its aberrant generation of contractile α-smooth muscle actin+ myofibroblasts. We will determine whether these cells pose a threat to pregnancy success, and whether the decidual gene silencing prevents their appearance by subverting the potent myofibroblast-inducing activity of TGF-β, a growth factor activated by wounding. Aim 3 will then determine how the decidual gene silencing program's ability to exclude activated T cells and macrophages from the maternal-fetal interface contributes to pregnancy success. Together, these aims will establish the importance of PRC2-mediated gene silencing in decidual biology, provide a greater understanding of the nature of uterine quiescence, and potentially reveal previously unappreciated threats to pregnancy relevant to human reproduction.
conceua是位于概念和子宫内部之间的专门子宫内膜组织 怀孕期间的几个重要功能。在这样做的同时,它也必须保持“静止”,否则会冒险 损害胎盘功能或触发子宫收缩,从而过早分娩。这个静止 已经假定状态像其他任何组织一样,因为它会被压力所消除 破坏组织稳态或完整性。但是,我们最近在老鼠中的工作表明该决定是独一无二的 因为它会积极执行自己的静止,并且发生这种情况是因为decideal基质细胞(DSC) 通过H3三甲基赖氨酸的靶向启动子重音27 (H3K27me3),一个反射性组蛋白标记。这个表观遗传程序影响了一组〜800个基因,并具有 我们目前理解的影响是抑制1型免疫学和伤口愈合反应。 H3K27me3由PRC2(Polycomb抑制复合物2)产生,其主要催化亚基是 组蛋白甲基转移酶EZH2(Zeste同源物2的增强子)。在这里,我们建议剖析怀孕 EZH2在子宫内有条件删除的小鼠的表型,其长期目标是获得A 更深入地了解子宫静止的性质以及对怀孕的威胁的种类 判决基因沉默计划。重要的是,“ EZH2 CKO”小鼠形成植入部位,但它们是短的 居住。我们假设H3K27me3介导的DSC中的基因沉默对怀孕至关重要,因为它 面对许多潜在的组织应力,包括 在AIM 1中 接近EZH2 CKO表型,我们将确定妊娠并发症的种类 子宫EZH2缺乏症以及可能触发这些的组织应力的产生 并发症。该目标侧重于(1)植入和早期胚胎发育引起的压力, (2)后来的斑点发育,(3)全身感染和(4)直接感染。 AIM 2然后解决 EZH2 CKO CASICUA的方面已经很清楚,即其异常产生的收缩α-Smoth 肌肉肌动蛋白+肌纤维细胞。我们将确定这些细胞是否对妊娠成功构成威胁,以及 Decideal基因沉默是否通过颠覆有效的肌纤维细胞诱导来阻止其外观 TGF-β的活性,这是通过获胜而激活的生长因子。 AIM 3然后将确定Decidel基因如何 沉默计划将活化的T细胞和巨噬细胞排除在母亲界面上的能力 有助于怀孕成功。这些目标共同确定PRC2介导的基因的重要性 沉默的判决生物学,对子宫静止的性质有更深入的了解,并且 可能揭示了先前对与人类繁殖有关的妊娠的不受欢迎的威胁。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adrian Erlebacher其他文献

Adrian Erlebacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adrian Erlebacher', 18)}}的其他基金

Immunological, epigenetic and developmental determinants of early pregnancy success
早期妊娠成功的免疫学、表观遗传学和发育决定因素
  • 批准号:
    10673393
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
Epigenetics of decidual inflammation
蜕膜炎症的表观遗传学
  • 批准号:
    10673396
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10673394
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
The IL-33/ILC2 axis in parturition
分娩时的 IL-33/ILC2 轴
  • 批准号:
    10318956
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
Predoctrol Training in Biomedical Sciences
生物医学科学博士前培训
  • 批准号:
    10669046
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
The IL-33/ILC2 axis in parturition
分娩时的 IL-33/ILC2 轴
  • 批准号:
    10543446
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
Predoctrol Training in Biomedical Sciences
生物医学科学博士前培训
  • 批准号:
    10440361
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
The IL-33/ILC2 axis in parturition
分娩时的 IL-33/ILC2 轴
  • 批准号:
    9916253
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
The IL-33/ILC2 axis in parturition
分娩时的 IL-33/ILC2 轴
  • 批准号:
    10083186
  • 财政年份:
    2020
  • 资助金额:
    $ 62.18万
  • 项目类别:
Epigenetics of uterine quiescence
子宫静止的表观遗传学
  • 批准号:
    10512053
  • 财政年份:
    2018
  • 资助金额:
    $ 62.18万
  • 项目类别:

相似国自然基金

KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
    82200258
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
    82171845
  • 批准年份:
    2021
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
  • 批准号:
    32102530
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
  • 批准号:
    10709381
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
Multi-omic phenotyping of human transcriptional regulators
人类转录调节因子的多组学表型分析
  • 批准号:
    10733155
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
  • 批准号:
    10658665
  • 财政年份:
    2023
  • 资助金额:
    $ 62.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了